<code id='E3CC2F338E'></code><style id='E3CC2F338E'></style>
    • <acronym id='E3CC2F338E'></acronym>
      <center id='E3CC2F338E'><center id='E3CC2F338E'><tfoot id='E3CC2F338E'></tfoot></center><abbr id='E3CC2F338E'><dir id='E3CC2F338E'><tfoot id='E3CC2F338E'></tfoot><noframes id='E3CC2F338E'>

    • <optgroup id='E3CC2F338E'><strike id='E3CC2F338E'><sup id='E3CC2F338E'></sup></strike><code id='E3CC2F338E'></code></optgroup>
        1. <b id='E3CC2F338E'><label id='E3CC2F338E'><select id='E3CC2F338E'><dt id='E3CC2F338E'><span id='E3CC2F338E'></span></dt></select></label></b><u id='E3CC2F338E'></u>
          <i id='E3CC2F338E'><strike id='E3CC2F338E'><tt id='E3CC2F338E'><pre id='E3CC2F338E'></pre></tt></strike></i>

          leisure time

          leisure time

          author:focus    Page View:99521
          A Medicare health insurance card on top of several hundred-dollar bills, with Benjamin Franklin's eyes covered by pills.
          Adobe

          The public will soon find out whether the federal government is willing to meet the health insurance industry’s demands and deposit more money into the bank accounts of next year’s Medicare Advantage plans.

          Budget officials within the Biden administration started reviewing final payment regulations for 2025 Medicare Advantage plans last week after more than 42,000 public comments rolled into the federal government’s inbox. Those rules will come out no later than April 1.

          advertisement

          In February, the government proposed a modest cut to next year’s average benchmark payment for Medicare Advantage plans, which are privately run insurance policies that now cover more than 33 million Americans. However, insurers are still estimated to receive more money under the proposal, overall, due to the aggressive way they code the medical conditions of their members.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more
          Novo acquires Inversago for up to $1 billion
          Novo acquires Inversago for up to $1 billion

          LISELOTTESABROE/Scanpix/AFPviaGettyImagesFreshoffofthenewsthatitsdrugWegovymaynotjusthelppeoplelosew

          read more
          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more

          Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

          AdobeWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyo